• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Testicular cancer study reveals highest risk symptoms to aid diagnosis

Bioengineer by Bioengineer
July 3, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study has identified the highest risk symptoms that can indicate testicular cancer, in research that aims to improve diagnosis.

Testicular cancer is on the rise in the UK, with well over 2,000 new cases each year. The number of cases has increased by 27% since the late 1990s, and is expected to grow by 12% over the next two decades.

The research, by the University of Exeter Medical School, published in the British Journal of General Practice has found testicular enlargement (a lump or swelling) to be the biggest risk factor for testicular cancer. The finding that painful testicular enlargement may indicate cancer contradicts traditional teaching.

The study, led by Dr Elizabeth Shephard and Professor Willie Hamilton is the first to look at symptoms of testicular cancer reported in UK general practice (GP) surgeries. The research was funded by the National Institute for Health Research.

Dr Elizabeth Shephard, of the University of Exeter Medical School, said: "We know early and accurate diagnosis saves lives in cancer. The findings of our study give greater clarity on which patients GPs should refer for further investigation for suspected testicular cancer in order to get the best outcome for patients."

The study compared anonymised patient records of 1,398 men with testicular cancer to 4,956 controls in the year before their diagnosis, to determine which symptoms are associated with a higher risk of the disease.

Diagnosing the disease early often means shorter treatment times and fewer complications and it may help to improve fertility.

Professor Willie Hamilton, of the University of Exeter Medical School, said: "Despite recent improvements, the UK still lags well behind other countries on cancer survival. Our study showed that some cancers could be confused initially with other testicular conditions, likely leading to delays in diagnosis.

"We design the risk assessment tools we use in our studies to help GPs assess risk in 20 cancers and we're rolling out this work as part of efforts to help improve the number of lives that can be saved."

The findings support current National Institute for Health and Care Excellence (NICE) guidelines, and may help doctors decide when an ultrasound should be considered in men with symptoms of testicular cancer.

###

The paper, "Selection of men for investigation of possible testicular cancer in primary care: a large case-control study using electronic patient records", is available online. Authors are Elizabeth A Shephard and William T Hamilton.

Media Contact

Alex Morrison
[email protected]
44-013-927-24828
@uniofexeter

http://www.exeter.ac.uk

http://dx.doi.org/10.3399/bjgp18X697949

Share12Tweet8Share2ShareShareShare2

Related Posts

Deep Learning Uncovers Tetrahydrocarbazoles as Potent Broad-Spectrum Antitumor Agents with Click-Activated Targeted Cancer Therapy Approach

February 7, 2026

Newly Discovered Limonoid DHL-11 from Munronia henryi Targets IMPDH2 to Combat Triple-Negative Breast Cancer

February 7, 2026

New Discovery Reveals Why Ovarian Cancer Spreads Rapidly in the Abdomen

February 6, 2026

New Study Finds Americans Favor In-Clinic Screening Over At-Home Tests for Cervical Cancer

February 6, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evaluating Pediatric Emergency Care Quality in Ethiopia

TPMT Expression Predictions Linked to Azathioprine Side Effects

Improving Dementia Care with Enhanced Activity Kits

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.